Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Randox is a global leader in clinical diagnostics with over 40 years’ experience. The company has developed hundreds of tests for use across hospitals and laboratories worldwide. It played a major role during the COVID‑19 pandemic as the largest PCR testing provider in the UK and Ireland. Its proprietary Biochip Array Technology enables simultaneous detection of multiple analytes from one sample—revolutionizing laboratory efficiency—and its portfolio includes quality controls/calibrators (Acusera), molecular controls (Qnostics), external quality assessment schemes (RIQAS/QCMD), chemistry/immunoanalysers (“RX”/“Evidence” series) and direct-to-consumer health screening via “Randox Health” clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Randox.